Department of Analytical Chemistry for Pharmaceuticals, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki, 852-8521, Japan.
Department of Analytical Chemistry for Pharmaceuticals, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki, 852-8521, Japan; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt.
Anal Chim Acta. 2024 Jul 18;1313:342700. doi: 10.1016/j.aca.2024.342700. Epub 2024 May 10.
L-p-Boronophehylalanine (BPA) is used in boron neutron capture therapy (BNCT), which is a novel selective cancer radiotherapy technique. It is important to measure BPA levels in human blood for effective radiotherapy; a prompt gamma-ray spectrometer, ICP-AES, and ICP-MS have been used for this purpose. However, these methods require sophisticated and expensive apparatuses as well as experienced analysts. Herein, we propose an HPLC-FL method for the determination of BPA after precolumn derivatization. A new fluorogenic reagent for aryl boronic acid derivatives, namely, 4-iodobenzonitrile, was employed for the fluorogenic derivatization of BPA based on the Suzuki coupling reaction.
After the fluorogenic derivatization, a fluorescent cyanobiphenyl derivative is formed with maximum fluorescence at 335 nm after excitation at 290 nm. The developed method showed good linearity (r=0.997) over the concentration range of 0.5-1000 nmol/L, and the detection limit (S/N = 3) was 0.26 nmol/L. The proposed method is more sensitive than previously reported methods for the determination of BPA, including the ICP-MS. Finally, the proposed method was successively applied to the measurement of BPA in human whole blood samples with a good recovery rate (≥95.7 %) using only 10 μL of blood sample. The proposed method offers a simple and efficient solution for monitoring BPA levels in BNCT-treated patients.
4-Iodobenzonitrile was investigated as a new fluorogenic reagent for BPA based on Suzuki coupling. A new HPLC-FL method for BPA in whole blood samples with ultrasensitivity was developed. The developed method is superior in sensitivity to all previously reported methods for BPA. The method requires only a very small sample volume, making it suitable for micro-blood analysis of BPA via fingerstick sampling.
L-对-硼苯丙氨酸(BPA)用于硼中子俘获治疗(BNCT),这是一种新型的选择性癌症放射治疗技术。为了实现有效的放射治疗,测量人体血液中的 BPA 水平非常重要;为此,已经使用了快速伽马射线光谱仪、ICP-AES 和 ICP-MS。然而,这些方法需要复杂和昂贵的仪器以及经验丰富的分析师。在此,我们提出了一种在柱前衍生化后用于测定 BPA 的 HPLC-FL 方法。我们使用了一种新的芳基硼酸衍生物的荧光衍生试剂,即 4-碘苯腈,用于基于 Suzuki 偶联反应的 BPA 的荧光衍生化。
在荧光衍生化后,形成具有最大荧光的荧光氰基联苯衍生物,在 290nm 激发下最大荧光发射在 335nm。所开发的方法在 0.5-1000nmol/L 的浓度范围内具有良好的线性关系(r=0.997),检测限(S/N=3)为 0.26nmol/L。与之前报道的包括 ICP-MS 在内的 BPA 测定方法相比,该方法更灵敏。最后,该方法成功地应用于 BNCT 治疗患者的全血样本中 BPA 的测定,仅使用 10μL 血样即可获得良好的回收率(≥95.7%)。该方法为 BNCT 治疗患者的 BPA 水平监测提供了一种简单有效的解决方案。
研究了 4-碘苯腈作为基于 Suzuki 偶联的 BPA 的新荧光衍生试剂。开发了一种用于全血样品中具有超高灵敏度的 BPA 的新 HPLC-FL 方法。与之前报道的所有 BPA 方法相比,该方法在灵敏度方面具有优势。该方法仅需要非常小的样本量,使其适合通过指尖采血进行 BPA 的微量血液分析。